An application made for this job — a tailored resume and cover letter that speak straight to the posting.
The University of Leeds invites applications for a Research Fellow in Qualitative Methods. You will lead qualitative studies in autoimmune connective tissue diseases, notably SLE, contributing to methodological development within the Leeds Institute of Rheumatic and Musculoskeletal Medicine.
Based at Chapel Allerton Hospital with hybrid working, the role requires strong organizational skills and collaboration across research themes.
This job is only available to University of Leeds staff. It may be released externally should we not appoint internally.
Do you have experience in undertaking qualitative research in autoimmune connective tissue diseases such as systemic lupus erythematosus (SLE)? Do you have excellent organisational skills and attention to detail? Do you want to be part of a successful, highly talented and leading research team? Are you keen to expand knowledge into this field and work collaboratively across research themes? Do you want to further your career in one of the UK's leading research intensive Universities?
SLE is one of a group of connective tissue diseases characterised by inflammation in multiple organs, type I interferon activity, and autoantibodies, leading to poor quality of life. It is more severe in children and people of non-European ancestry groups. Current practice is to treat SLE with a series of conventional immunosuppressants combined with glucocorticoids (GC), but evidence for the sequence in which they should be used is weak. Under current clinical guidelines, if this approach fails, and people have moderate/severe SLE, a more effective biological therapy such as rituximab, can be added to these agents later as usual care. This approach may not be optimal since SLE is most severe within the first 12 months of diagnosis, with the highest mortality, GC exposure and healthcare resource use.
Our current work aims to advance understanding on the clinical and cost-effectiveness of biological therapies given first-line or after failure of conventional immunosuppressants in people with moderate to severe SLE, as well as optimising outcome measures/treatment targets used in clinical trials and clinical practice. Since health outcome disparities exist in SLE, for this role, our work also aims to improve understanding and evaluate strategies to enhance recruitment of people from underserved groups, children and ethnic minorities into clinical trials. Qualitative research and patient public engagement are essential parts of this role.
You will lead your own studies in this area, including methods development and clinical studies and contribute to the work of the research group as a whole.
Chapel Allerton Hospital (with scope for hybrid working)
Please note that this post may be suitable for sponsorship under the Skilled Worker visa route but first-time applicants might need to qualify for salary concessions. For more information please visit: www.gov.uk/skilled-worker-visa.
For research and academic posts, we will consider eligibility under the Global Talent visa. For more information please visit: https://www.gov.uk/global-talent
Professor Edward Vital, Leeds Institute of Rheumatic and Musculoskeletal Medicine
Tel: +44 (0)113 3438412, Email: e.m.j.vital@leeds.ac.uk
Faculty of Medicine & Health
Leeds Institute of Rheumatic & Musculoskeletal Medicine (LIRMM)
Research
Grade 7
£41,064 to £48,822 per annum pro-rata
45% FTE - 16.87 hours per week
Part Time
Fixed Term (Available for 15 months to complete a specific task or time limited work, including the need for specific expertise or additional resource for a project)
Monday 14 September 2026
Monday 21 September 2026
Wednesday 30 September 2026